Rejection Prophylaxis
Rejection Prophylaxis is a transplant pharmacotherapy strategy that employs planned immunosuppressive regimens initiated before or immediately after organ or tissue transplantation to prevent, rather than treat, immune-mediated graft rejection.
518
Publications
27.5K
Citations
3.6K
Authors
788
Institutions
Publications per year
2017–2026
69
Variants
Transplant Rejection Prophylaxis
Parents
518
Richard A. Nash, Joseph H. Antin, Chatchada Karanes et al. · PubMed · 2000 · 591 citations
Voravit Ratanatharathorn, Richard A. Nash, Donna Przepiorka et al. · PubMed · 1998 · 568 citations
Outcomes of Kidney Transplantation in HIV-Infected Recipients
Peter G. Stock, Burc Barin, Barbara Murphy et al. · New England Journal of Medicine · 2010 · 527 citations · Full text
Andrea Bacigalupo, Teresa Lamparelli, Paolo Bruzzi et al. · Blood · 2001 · 524 citations · Full text
Life Sciences, Immunology, Surgery +14
1–5 of 518
3.6K
12
h-index
10
h-index
9
h-index
9
h-index
8
h-index
1–5 of 3.6K
788
University of Washington
Seattle, United States
17 h-index
90 publications
6.3K citations
Fred Hutch Cancer Center
Seattle, United States
17 h-index
108 publications
18.6K citations
Emory University
Atlanta, United States
15 h-index
33 publications
2.2K citations

Johns Hopkins University
Baltimore, United States
12 h-index
60 publications
4.1K citations
University of Pittsburgh
Pittsburgh, United States
12 h-index
34 publications
2.1K citations
University of California, San Francisco
San Francisco, United States
12 h-index
21 publications
2.9K citations
Cleveland Clinic
Cleveland, United States
11 h-index
40 publications
1.6K citations
Inserm
Paris, France
11 h-index
50 publications
2.8K citations
1–8 of 788
55 publications · 3.4K citations
35
h-index
Repository · 92 publications · 4.1K citations
33
h-index
29 publications · 3.8K citations
23
h-index
49 publications · 1K citations
21
h-index
22 publications · 2.6K citations
19
h-index
1–5